LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Home・Aktien・Pulmatrix Inc

Pulmatrix Inc

Geschlossen

1.36

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.24

Max

1.3599999999999999

Schlüsselkennzahlen
By Trading Economics
Einkommen	-244K -1.2M
EPS	-0.321
Angestellte	2
EBITDA	-364K -1.3M

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	256K 4.8M
Vorheriger Eröffnungskurs	1.36
Vorheriger Schlusskurs	1.36

Pulmatrix Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Mai 2026, 23:08 UTC

Akquisitionen, Fusionen, Übernahmen

Family Offices Bypass Private Equity and Go Direct -- Barrons.com

29. Mai 2026, 23:06 UTC

Akquisitionen, Fusionen, Übernahmen

After a Series of Sales, Hims Director Buys Company Shares -- Barrons.com

29. Mai 2026, 20:53 UTC

Ergebnisse

Oil Declines Lift Stocks to Fresh Records -- WSJ

29. Mai 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 20:33 UTC

Market Talk

Canada Meets Only One of Three Criteria To Declare Recession -- Market Talk

29. Mai 2026, 20:11 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 19:47 UTC

Ergebnisse

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

29. Mai 2026, 19:36 UTC

Market Talk

U.S. Natural Gas Futures End Month With Gains -- Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Over Half of Canadian Industries Growing, Undermining Recession Talk -- Market Talk

29. Mai 2026, 19:22 UTC

Market Talk

Oil Falls as U.S., Iran Expected to Reach Agreement -- Market Talk

29. Mai 2026, 19:05 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Takeover Bid From Bill Ackman's Pershing Square -- Barrons.com

29. Mai 2026, 18:19 UTC

Market Talk

Canada Technical Recession Chatter Rife But Per-Capita GDP Was Up -- Market Talk

29. Mai 2026, 18:12 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman -- WSJ

29. Mai 2026, 18:11 UTC

Market Talk

Canada Households Reaching Limit at Keeping Spending in Positive Territory -- Market Talk

29. Mai 2026, 18:10 UTC

Market Talk

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29. Mai 2026, 17:55 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 17:55 UTC

Market Talk

NEAR Protocol Nearly Doubles in May -- Market Talk

29. Mai 2026, 17:38 UTC

Market Talk

U.S. Oil Rig Count Rises for Fifth Straight Week -- Market Talk

29. Mai 2026, 17:00 UTC

Ergebnisse

Okta Stock Soars After Earnings. Results Aren't the Real Catalyst. -- Barrons.com

29. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

29. Mai 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29. Mai 2026, 16:02 UTC

Market Talk

Gold Extend Gains as Investors Await U.S.-Iran Deal News -- Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Global Equities Roundup: Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Cryptocurrencies Appear Detached From Stocks -- Market Talk

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Cormetech Acquisition to Drive Growth

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Demand for AI Data Centers Insatiable

29. Mai 2026, 15:40 UTC

Market Talk

Kalshi To Launch Crypto Perpetual Futures -- Market Talk

29. Mai 2026, 15:20 UTC

Market Talk

Canada's Economy Not Looking All That Bright -- Market Talk

Peer-Vergleich

Kursveränderung

Pulmatrix Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pulmatrix Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.